Darifenacin 7.5 mg | DRIFENACIN 7.5
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Darifenacin Prolonged-Release Tablets IP 7.5 mg
Rs 157.26
MRP Rs 224.66
(30% OFF)
Includes all taxes
Package SIZE
( For 10 Tabs )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
What Is Darifenacin 7.5 mg?
Darifenacin 7.5 mg is generally supplied as an extended-release/prolonged-release tablet containing 7.5 mg of darifenacin. It is a selective muscarinic M3 receptor antagonist. The M3 receptor is an important receptor involved in bladder muscle contraction. By reducing unwanted bladder contractions, darifenacin can help improve bladder storage and control.
Unlike an antibiotic, painkiller, or diuretic, Darifenacin 7.5 mg is specifically intended to control symptoms associated with overactive bladder.
Key uses include:
- Urinary urgency
- Frequent urination
- Urge urinary incontinence
- Other symptoms associated with overactive bladder syndrome
It does not treat every possible cause of frequent urination. For example, urinary infection, diabetes, certain prostate conditions, and other medical problems may produce similar symptoms and require different treatment.
Darifenacin 7.5 mg Uses
1. Overactive Bladder
The primary indication for Darifenacin 7.5 mg is symptomatic treatment of overactive bladder. OAB can cause a sudden need to urinate, frequent trips to the bathroom, and involuntary urine leakage. Darifenacin is designed to reduce these symptoms.
2. Urinary Urgency
Urinary urgency means experiencing a sudden, difficult-to-delay need to urinate. By reducing involuntary bladder contractions, darifenacin may help patients gain better control over urinary urgency.
3. Frequent Urination
People with OAB may need to urinate unusually often. Darifenacin can help reduce urinary frequency as part of overall OAB symptom management.
4. Urge Urinary Incontinence
Urge urinary incontinence occurs when a strong urge to urinate is followed by involuntary urine leakage. Darifenacin is indicated for this type of OAB-related symptom.
How Does Darifenacin 7.5 mg Work?
Darifenacin works primarily by blocking muscarinic M3 receptors in the bladder. These receptors are involved in contraction of the detrusor muscle, which is the main muscle responsible for emptying the bladder.
By reducing unwanted contractions, darifenacin can increase bladder capacity and help decrease episodes of urgency, frequency, and urge incontinence. Clinical studies have demonstrated improvements in incontinence episodes with 7.5 mg and 15 mg daily doses compared with placebo.
This means Darifenacin 7.5 mg is intended to improve bladder control, rather than simply masking urinary symptoms.
Key Benefits of Darifenacin 7.5 mg
1. Helps control urinary urgency
Darifenacin may reduce sudden, difficult-to-delay urges to urinate.
2. Helps reduce urinary frequency
By improving bladder storage, treatment may help reduce unnecessarily frequent bathroom visits.
3. Helps manage urge-related urine leakage
Patients experiencing urge urinary incontinence may experience fewer leakage episodes when the medicine is effective.
4. Convenient once-daily treatment
The recommended starting dose is 7.5 mg once daily, making it a convenient dosing schedule for many patients.
However, “once daily” does not mean the medicine is appropriate for everyone. The correct treatment plan depends on individual health conditions, other medicines, and response to treatment.
Darifenacin 7.5 mg Dosage and How to Take It
The recommended starting dose of extended-release darifenacin is 7.5 mg once daily. After approximately two weeks, a healthcare professional may reassess the response. If greater symptom relief is needed and the medicine is tolerated, the dose may be increased to 15 mg once daily.
Darifenacin extended-release tablets should generally be:
- Taken once daily with water
- Taken with or without food
- Swallowed whole
- Not chewed, divided, or crushed because they are extended-release tablets
Can you increase Darifenacin 7.5 mg yourself?
No. Do not increase the dose from 7.5 mg to 15 mg without medical advice.
The maximum recommended daily dose may be restricted to 7.5 mg in people with moderate hepatic impairment or those taking potent CYP3A4 inhibitors. Darifenacin is not recommended in severe hepatic impairment according to U.S. prescribing information.
Darifenacin 7.5 mg Side Effects
Like all medicines, Darifenacin 7.5 mg can cause side effects, although not everyone experiences them.
The most commonly reported adverse effects are:
- Dry mouth
- Constipation
- Headache
- Abdominal pain
- Nausea
- Indigestion
- Dry eyes
- Dizziness
- Somnolence
- Visual disturbances
Current product information identifies dry mouth and constipation as particularly common adverse reactions. At the 7.5 mg dose, dry mouth occurred in approximately 20.2% and constipation in approximately 14.8% of patients in the cited clinical data.
Serious or Important Side Effects
Although less common, important reactions can include:
- Urinary retention
- Significant visual disturbances
- Severe allergic reactions, including angioedema
- Severe gastrointestinal effects
- Confusion or other central nervous system effects in susceptible individuals
Urinary retention is particularly important because darifenacin can make bladder emptying more difficult.
Seek prompt medical attention if you develop severe difficulty passing urine, significant swelling of the face/throat, breathing difficulty, or another serious unexpected reaction.
Who Should Avoid or Use Darifenacin With Caution?
Darifenacin is contraindicated in certain conditions, including urinary retention, gastric retention, and uncontrolled narrow-angle glaucoma.
Tell your healthcare professional if you have:
- Difficulty emptying your bladder
- Bladder outlet obstruction
- Severe constipation or gastrointestinal obstruction
- Glaucoma
- Liver disease
- Kidney problems
- Heart or blood-pressure concerns
- A history of medication allergies
Older adults may also require careful assessment because anticholinergic medicines can produce effects such as constipation, dizziness, visual disturbances, and confusion in susceptible individuals.
Darifenacin 7.5 mg Drug Interactions
Darifenacin can interact with other medicines, particularly potent CYP3A4 inhibitors. Examples listed in prescribing information include certain antifungal medicines, macrolide antibiotics, and some antiviral medicines.
Before starting Darifenacin 7.5 mg, tell your doctor or pharmacist about:
- Prescription medicines
- Over-the-counter medicines
- Vitamins
- Herbal supplements
- Other bladder medicines
Do not start or stop another medicine solely on the basis of online information.
Darifenacin 7.5 mg During Pregnancy and Breastfeeding
Pregnancy requires individualized medical assessment. Current U.S. prescribing information states that darifenacin should be used during pregnancy only when the potential benefit to the mother outweighs potential fetal risk. It is also not known with certainty whether darifenacin passes into human milk, so caution is advised during breastfeeding.
If you are pregnant, planning pregnancy, or breastfeeding, discuss Darifenacin 7.5 mg with your healthcare professional before using it.
Darifenacin 7.5 mg: Buyer-Intent Guide
Before purchasing, verify:
- Correct medicine name
- 7.5 mg strength
- Extended-release formulation
- Manufacturer
- Batch number
- Expiry date
- Intact packaging
- Licensed/legitimate pharmacy
- Prescription requirements
Avoid purchasing prescription medicines from websites offering unusually low prices or selling them without appropriate medical oversight.
Frequently Asked Questions
1. What is darifenacin 7.5 mg used for?
Darifenacin 7.5 mg is used to treat overactive bladder symptoms, particularly urinary urgency, increased urinary frequency, and urge urinary incontinence.
2. Is Darifenacin 7.5 mg a painkiller?
No. Darifenacin is not a conventional painkiller. It is an antimuscarinic medicine that acts on bladder receptors to reduce unwanted bladder contractions.
3. How often should Darifenacin 7.5 mg be taken?
The usual starting regimen is 7.5 mg once daily. Depending on individual response and tolerability, a doctor may increase it to 15 mg once daily after about two weeks.
4. What are the most common Darifenacin 7.5 mg side effects?
The most common side effects are dry mouth and constipation. Headache, abdominal discomfort, nausea, dizziness, dry eyes, and visual disturbances may also occur.
5. Can Darifenacin 7.5 mg cause constipation?
Yes. Constipation is one of the most frequently reported side effects of darifenacin and may be dose-related. Contact a healthcare professional if constipation becomes severe or persistent.
6. Can Darifenacin 7.5 mg be increased to 15 mg?
It can be increased to 15 mg once daily when clinically appropriate and prescribed by a healthcare professional. Certain patients, including those with moderate hepatic impairment or taking potent CYP3A4 inhibitors, should not exceed 7.5 mg daily.
7. Can Darifenacin 7.5 mg be crushed?
No. Because it is an extended-release formulation, the tablet should be swallowed whole rather than chewed, divided, or crushed.
8. How long should I take Darifenacin 7.5 mg?
Treatment duration depends on your symptoms, response, side effects, and underlying condition. Your prescriber should determine how long treatment should continue.
Conclusion
Darifenacin 7.5 mg is a prescription antimuscarinic medicine primarily used for overactive bladder, including urinary urgency, increased urinary frequency, and urge urinary incontinence. It works mainly through M3 muscarinic receptor blockade to reduce unwanted bladder contractions and improve bladder control.